Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus – Candida albicans Dual-Species Communities’ Growth Model
Microbial Drug Resistance · 01.06.2022 · 28 (6) · 613-622
DOI: 10.1089/mdr.2021.0324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, online erschienen am 10.06.2022. Verfasst von Marta Roszak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chair of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Szczecin, Po…. Hauptthemen laut MEDLINE: Bacteriophages, Staphylococcal Infections. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Alternative therapies against multidrug-resistant bacteria are widely investigated in the postantibiotic era. Polymicrobial biofilms formed by two or more species of bacteria or fungi pose an additional threat. The removal of such complex communities requires more effort and a multidirectional approach. In this study, the effectiveness of two bacteriophages vB_SauM-A (A) and vB_SauM-D (D) combined with ciprofloxacin was used to combat Staphylococcus aureus in the presence of Candida albicans both in liquid culture and biofilm. The results showed that phage-antibiotic synergy (PAS) led to the complete removal of S. aureus in liquid culture without bacterial population regrowth after 24 hours, and C. albicans enhanced this therapeutic effect. In a biofilm assay, C. albicans presence caused a decrease of bacterial eradication and a reduction of biofilm-specific activity (BSA). However, the strong effect of PAS was observed both in mono- and dual-species biofilm. Usage of phages and ciprofloxacin (1 mg/L) caused a 90% reduction of BSA of mono-species biofilm and 69% of dual-species biofilm. Phages alone resulted in a decrease of 71% and 48%, and ciprofloxacin (1 mg/L) alone resulted in 45% and 23% reduction, respectively. The influence of C. albicans on the PAS effect against S. aureus presented in this study was not previously investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Chair of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
- Department of Chemical and Process Engineering, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Szczecin, Poland.
ORCID-Profile: Marta Roszak, Joanna Jabłońska, Bartłomiej Grygorcewicz
Zitieren
APA
Roszak, M., Dołęgowska, B., Cecerska-Heryć, E., Serwin, N., Jabłońska, J., & Grygorcewicz, B. (2022). Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus – Candida albicans Dual-Species Communities’ Growth Model. Microbial Drug Resistance, 28(6), 613-622. https://doi.org/10.1089/mdr.2021.0324
Vancouver
Roszak M, Dołęgowska B, Cecerska-Heryć E, Serwin N, Jabłońska J, Grygorcewicz B. Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus – Candida albicans Dual-Species Communities’ Growth Model. Microbial Drug Resistance. 2022;28(6):613-622. doi:10.1089/mdr.2021.0324
BibTeX
@article{Roszak2022,
author = {Roszak, Marta and Dołęgowska, Barbara and Cecerska-Heryć, Elżbieta and Serwin, Natalia and Jabłońska, Joanna and Grygorcewicz, Bartłomiej},
title = {Bacteriophage–Ciprofloxacin Combination Effectiveness Depends on Staphylococcus aureus – Candida albicans Dual-Species Communities’ Growth Model},
journal = {Microbial Drug Resistance},
year = {2022},
volume = {28},
number = {6},
pages = {613--622},
doi = {10.1089/mdr.2021.0324}
}
EUVIMED